HPV vaccination--more answers, more questions.
Sawaya
George F
GF
Smith-McCune
Karen
K
D000230:Adenocarcinoma / Q000517:prevention & control; D052685:Alphapapillomavirus; D002648:Child; D003218:Condylomata Acuminata / Q000517:prevention & control; D005260:Female; D005833:Genital Neoplasms, Female / Q000517:prevention & control; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D030361:Papillomavirus Infections / Q000517:prevention & control; D053918:Papillomavirus Vaccines; D018570:Risk Assessment; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control*; D002578:Uterine Cervical Dysplasia / Q000517:prevention & control*
D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines